Kare Chemical Technologies
2 known investors
Kare Chem designs ligands—high-affinity chemical compounds that modulate receptor pathways—for treatment of pain, neurological disorders, inflammation, and CNS conditions including epilepsy, ADHD, and anxiety. The company serves pharmaceutical and research organizations developing therapeutics targeting CB1 and CB2 receptor pathways.